Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing 76 - 100 of 1,589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Xiamen (Organoid culture)

Recruiting
  • Ovarian Cancer
  • Organoid culture
  • Xiamen, Fujian, China
    First Affiliated Hospital of Xiamen University
Apr 3, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

Ovarian Cancer, Frailty Trial in Denmark (Comprehensive geriatric assessment and individualised physical training)

Recruiting
  • Ovarian Cancer
  • Frailty
  • Comprehensive geriatric assessment and individualised physical training
  • Odense, Region Of South Denmark, Denmark
  • +4 more
Mar 31, 2023

Gynecologic Cancer, Cervical Cancer, Endometrial Cancer Trial in Taoyuan City (Hyperpolarized 13C-Pyruvate injection)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Hyperpolarized 13C-Pyruvate injection
  • Taoyuan City, Guishan District, Taiwan
    Chang Gung Memorial Hospital
Apr 5, 2023

Ovarian Cancer Trial (Gleolan)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 27, 2023

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Ovarian Cancer
  • +2 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Mar 26, 2023

Appraising Medical Trial Experiences of Ovarian Cancer Patients

Not yet recruiting
  • Ovarian Cancer
    • (no location specified)
    Mar 24, 2023

    Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

    Not yet recruiting
    • Ovarian Cancer
    • Lung Adenocarcinoma
    • Duarte, California
    • +6 more
    Mar 21, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +13 more
    • (no location specified)
    Mar 29, 2023

    Ovarian Cancer Trial in Hangzhou (NKG2D CAR-NK)

    Recruiting
    • Ovarian Cancer
    • NKG2D CAR-NK
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Mar 26, 2023

    Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • +4 more
    • Houston, Texas
      MD Anderson
    Mar 27, 2023

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Ovarian Cancer Trial in New Haven, Miami (Exercise and medical nutrition)

    Not yet recruiting
    • Ovarian Cancer
    • Exercise and medical nutrition
    • New Haven, Connecticut
    • +1 more
    Feb 27, 2023

    Ovarian Cancer Trial (Huaier granule)

    Not yet recruiting
    • Ovarian Cancer
    • Huaier granule
    • (no location specified)
    Feb 28, 2023

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)

      Not yet recruiting
      • Ovarian Cancer
      • +3 more
      • NM1F Injection
      • Pembrolizumab injection
      • (no location specified)
      Feb 23, 2023

      Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • (no location specified)
      Feb 24, 2023

      Adherence and Compliance to ERAS in Gynecological Surgery

      Not yet recruiting
      • ERAS
      • +7 more
      • Assessment of compliance to ERAS.
      • Brescia, BS, Italy
        Federico Ferrari
      Feb 13, 2023

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

      Recruiting
      • Ovarian Cancer
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Feb 13, 2023

      Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

      Not yet recruiting
      • Breast Cancer
      • +8 more
      • (no location specified)
      Feb 9, 2023

      Genetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer Trial in Philadelphia (Sequential EHR Communications)

      Not yet recruiting
      • Genetic Predisposition to Disease
      • +6 more
      • Sequential EHR Communications
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Feb 8, 2023

      Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

      Not yet recruiting
      • Ovarian Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

      Not yet recruiting
      • Cancer
      • +16 more
      • KVA12123 - Dose Escalation
      • +3 more
      • (no location specified)
      Feb 2, 2023

      Development ofDecision Aid to Facilitate Ovarian Cancer

      Completed
      • Ovarian Cancer
        • Vejle, Denmark
          Department of Oncology, Vejle Hospital
        Feb 2, 2023